Your browser doesn't support javascript.
Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications.
Paudel, Keshav Raj; Patel, Vyoma; Vishwas, Sukriti; Gupta, Saurabh; Sharma, Sumit; Chan, Yinghan; Jha, Niraj Kumar; Shrestha, Jesus; Imran, Mohammad; Panth, Nisha; Shukla, Shakti Dhar; Jha, Saurav Kumar; Devkota, Hari Prasad; Warkiani, Majid Ebrahimi; Singh, Sachin Kumar; Ali, Md Khadem; Gupta, Gaurav; Chellappan, Dinesh Kumar; Hansbro, Philip M; Dua, Kamal.
  • Paudel KR; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia.
  • Patel V; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Vishwas S; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, Australia.
  • Gupta S; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Sharma S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
  • Chan Y; Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
  • Jha NK; Delhi Pharmaceutical Sciences and Research University, New Delhi, India.
  • Shrestha J; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
  • Imran M; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Nioda, India.
  • Panth N; School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Shukla SD; Therapeutics Research Group, The University of Queensland Diamantina Institute, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Jha SK; Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, Australia.
  • Devkota HP; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Warkiani ME; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, Australia.
  • Singh SK; Department of Biomedicine, Health and Life Convergence Sciences, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, Korea.
  • Ali MK; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Gupta G; School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Chellappan DK; Institute for Biomedical Materials and Devices, Faculty of Science, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Hansbro PM; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, Australia.
  • Dua K; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
J Food Biochem ; : e14445, 2022 Oct 14.
Article in English | MEDLINE | ID: covidwho-2078554
ABSTRACT
Nutraceuticals have emerged as potential compounds to attenuate the COVID-19 complications. Precisely, these food additives strengthen the overall COVID treatment and enhance the immunity of a person. Such compounds have been used at a large scale, in almost every household due to their better affordability and easy access. Therefore, current research is focused on developing newer advanced formulations from potential drug candidates including nutraceuticals with desirable properties viz, affordability, ease of availability, ease of administration, stability under room temperature, and potentially longer shelf-lives. As such, various nutraceutical-based products such as compounds could be promising agents for effectively managing COVID-19 symptoms and complications. Most importantly, regular consumption of such nutraceuticals has been shown to boost the immune system and prevent viral infections. Nutraceuticals such as vitamins, amino acids, flavonoids like curcumin, and probiotics have been studied for their role in the prevention of COVID-19 symptoms such as fever, pain, malaise, and dry cough. In this review, we have critically reviewed the potential of various nutraceutical-based therapeutics for the management of COVID-19. We searched the information relevant to our topic from search engines such as PubMed and Scopus using COVID-19, nutraceuticals, probiotics, and vitamins as a keyword. Any scientific literature published in a language other than English was excluded. PRACTICAL APPLICATIONS Nutraceuticals possess both nutritional values and medicinal properties. They can aid in the prevention and treatment of diseases, as well as promote physical health and the immune system, normalizing body functions, and improving longevity. Recently, nutraceuticals such as probiotics, vitamins, polyunsaturated fatty acids, trace minerals, and medicinal plants have attracted considerable attention and are widely regarded as potential alternatives to current therapeutic options for the effective management of various diseases, including COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Reviews Topics: Long Covid / Traditional medicine Language: English Journal: J Food Biochem Year: 2022 Document Type: Article Affiliation country: Jfbc.14445

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Reviews Topics: Long Covid / Traditional medicine Language: English Journal: J Food Biochem Year: 2022 Document Type: Article Affiliation country: Jfbc.14445